Pharmaceutical Benefits Advisory Committee Guidelines Review

Page last updated: 27 April 2015

The Minister for Health, Sussan Ley, has approved a review of the Pharmaceutical Benefits Advisory Committee’s (PBAC) submission guidelines to ensure Australians continue to have affordable and timely access to new medicines and products.

The Guidelines are used by the pharmaceutical industry to prepare submissions to the PBAC so it can assess whether a medicine or medicinal product should be included on the Pharmaceutical Benefits Scheme (PBS).

The Department of Health is seeking a qualified organisation to conduct the review of the PBAC Guidelines, and interested parties can view the tender and apply at www.tenders.gov.au.

Further information on the Guidelines Review is available on the PBAC Guidelines Review web page.